<DOC>
	<DOCNO>NCT01612065</DOCNO>
	<brief_summary>Misoprostol effective agent cervical priming office hysteroscopy , vaginal route best , optimum dose yet know .</brief_summary>
	<brief_title>Optimum Misoprostol Dose Prior Office Hysteroscopy</brief_title>
	<detailed_description>The investigator compare 2 different dos vaginal misoprostol , group ( 1 ) 200 ug , group ( 2 ) 400 ug , 3hours prior office hysteroscopy , Infertile patient , patient abnormal bleed patient recurrent abortion Outcome measure : pain score , easiness procedure , procedure time , complication</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Abortion , Habitual</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Female patient pre postmenopausal undergo office hysteroscopy . Age : 20 60 . BMI 18 30 . PID Heavy uterine bleed Cervical malignancy . Symptoms suggestive endometriosis . Any cervical abnormality pinhole cervix would obviate passage catheter cervix .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Office hysteroscopy</keyword>
	<keyword>Cervical priming</keyword>
	<keyword>Misoprostol</keyword>
</DOC>